David Sullivan
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 0.5%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
Papers in
- Surgery 90
- Lipoproteins and Cardiovascular Health 82
- Cholesterol and Lipid Metabolism 11
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 32
- Co-authors
- Anthony Keech (36 shared papers)Scott M. Wasserman (8 shared papers)Robert C. Scott (8 shared papers)Peter Clifton (15 shared papers)Gerald F. Watts (39 shared papers)Philip J. Barter (13 shared papers)David S. Celermajer (9 shared papers)Paul J. Nestel (17 shared papers)
- Journals
- Atherosclerosis (15 papers)Circulation (8 papers)Journal of clinical lipidology (6 papers)The Medical Journal of Australia (6 papers)Pathology (6 papers)
- Partner nations
- AustraliaNew ZealandUnited States
In The Last Decade
David Sullivan
204 papers receiving 9.5k citations
David Sullivan's Hit Papers
Peers
Comparison fields: 5 of 160
- Endocrinology, Diabetes and Metabolism 1.6k
- Surgery 3.9k
- Biochemistry 406
- Nutrition and Dietetics 1.0k
- Cardiology and Cardiovascular Medicine 1.4k
Countries citing papers authored by David Sullivan
This map shows the geographic impact of David Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sullivan more than expected).
Fields of papers citing papers by David Sullivan
This network shows the impact of papers produced by David Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sullivan. The network helps show where David Sullivan may publish in the future.
Co-authors
The 25 scholars most cited alongside David Sullivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 212 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Health benefits of herbs and spices: the past, the present, the future Hit paper breakdown → | 2006 | 788 |
| 2 | PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2014 | 588 |
| 3 | Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance Hit paper breakdown → | 2014 | 434 |
| 4 | Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients Hit paper breakdown → | 2012 | 375 |
| 5 | 2010 | 277 | |
| 6 | 1990 | 225 | |
| 7 | 2017 | 215 | |
| 8 | 2002 | 203 | |
| 9 | 1985 | 187 | |
| 10 | 2013 | 182 | |
| 11 | 1997 | 161 | |
| 12 | 2012 | 157 | |
| 13 | 2004 | 156 | |
| 14 | 1986 | 152 | |
| 15 | 1997 | 147 | |
| 16 | 2008 | 144 | |
| 17 | 1985 | 140 | |
| 18 | 2015 | 137 | |
| 19 | 2014 | 135 | |
| 20 | 1990 | 132 |
About David Sullivan
David Sullivan is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Cancer Research and Molecular Biology, having authored 212 papers that have together received 10.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (82 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (32 papers), Cancer, Lipids, and Metabolism (29 papers), Lipid metabolism and disorders (14 papers), Fatty Acid Research and Health (12 papers), Metabolomics and Mass Spectrometry Studies (12 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Cholesterol and Lipid Metabolism (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Surgery (3.9k citations), Biochemistry (406 citations), Nutrition and Dietetics (1.0k citations) and Cardiology and Cardiovascular Medicine (1.4k citations). David Sullivan has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include Anthony Keech, Scott M. Wasserman, Robert C. Scott, Peter Clifton, Gerald F. Watts, Philip J. Barter, David S. Celermajer, Paul J. Nestel, Russell Scott and G. R. Thompson. Their work appears in journals such as Atherosclerosis, Circulation, Journal of clinical lipidology, The Medical Journal of Australia and Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.